AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Leite, KRM Franco, MF Srougi, M Nesrallah, LJ Nesrallah, A Bevilacqua, RG Darini, E Carvalho, CM Meirelles, MI Santana, I Camara-Lopes, LH
Citation: Krm. Leite et al., Abnormal expression of MDM2 in prostate carcinoma, MOD PATHOL, 14(5), 2001, pp. 428-436

Authors: Machado, MAC Herman, P Montagnini, AL Jukemura, J Leite, KRM Machado, MCC
Citation: Mac. Machado et al., Benign variant of osteoclast-type giant cell tumor of the pancreas: Importance of the lack of epithelial differentiation, PANCREAS, 22(1), 2001, pp. 105-107

Authors: Srougi, M Nesrallah, LJ Kauffmann, JR Nesrallah, A Leite, KRM
Citation: M. Srougi et al., Urinary continence and pathological outcome after bladder neck preservation during radical retropubic prostatectomy: A randomized prospective trial, J UROL, 165(3), 2001, pp. 815-818

Authors: de Araujo, VC Martins, MT Leite, KRM Gomez, RS de Araujo, NS
Citation: Vc. De Araujo et al., Immunohistochemical Mdm2 expression in minor salivary gland tumours and its relationship to p53 gene status, ORAL ONCOL, 36(1), 2000, pp. 67-69

Authors: Leite, KRM Garicochea, B Srougi, M Dzik, C Nesralhah, L de Moura, RP Simpson, AJG Darini, E Carvalho, CM Camara-Lopes, LH
Citation: Krm. Leite et al., Monoclonality of asynchronous bilateral lymphoma of the testis, EUR UROL, 38(6), 2000, pp. 774-777

Authors: Leite, KRM de Araujo, VC Meirelles, MIR Costa, AD Camara-Lopes, LH
Citation: Krm. Leite et al., No relationship between proliferative activity and the macis prognostic scoring system in papillary thyroid carcinoma, HEAD NECK, 21(7), 1999, pp. 602-605

Authors: Leite, KRM Srougi, M Nesralhah, LJ Camara-Lopes, LH
Citation: Krm. Leite et al., Analysis of p53 expression and proliferative assessment using PCNA in localized prostate carcinoma, BRAZ J MED, 32(3), 1999, pp. 283-288

Authors: Srougi, M Kauffmann, JR Nesrallah, A Leite, KRM
Citation: M. Srougi et al., High Gleason score predicts poor pathologic outcome after neoadjuvant androgen deprivation for locally advanced prostate cancer, MOL UROL, 2(3), 1998, pp. 195-199
Risultati: 1-8 |